Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01175044 · ClinicalTrials.gov registry record · Phase 4

Dilute Betadine Lavage in the Prevention of Postoperative Infection

A Phase 4 study of Arthroplasty and Prosthesis-related Infections, sponsored by Rush University Medical Center.

Completed
Registry status
Phase 4
Development phase
505
Enrollment target
2
Study locations

NCT01175044: Completed Phase 4 study of Arthroplasty and Prosthesis-related Infections, sponsored by Rush University Medical Center.

NCT01175044 is a Phase 4 study of Arthroplasty and Prosthesis-related Infections that has completed, run by Rush University Medical Center. The registered enrollment target is 505 participants, above the 140-participant average among 5 other Arthroplasty trials with a reported enrollment target (261% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01175044, a Phase 4 study of Arthroplasty and Prosthesis-related Infections, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
505 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to examine the efficacy of a dilute betadine solution in reducing infectious complications in revision total knee arthroplasty. The investigators will enroll patients who are scheduled to undergo a revision total knee arthroplasty. Patients will be randomized into two groups. The treatment group will receive a dilute betadine lavage prior to surgical closure for 3 minutes followed by 2000ml of sterile saline irrigation and the control group will receive the 2000ml sterile saline lavage alone.

Interventions

  • PROCEDURE Betadine Lavage
  • PROCEDURE Saline Lavage

Study Locations (2)

Illinois

  • Rush University Medical Center - Chicago
  • Central DuPage Hospital - Winfield

Trial Details

FieldValue
Enrollment Target 505 participants
Start Date 2010-08
Est. Completion 2019-07-08
Phase Phase 4
Rush University Medical Center

320 total trials

What the finished NCT01175044 record still lists

NCT01175044 is an interventional study that assigns participants to a tested intervention. The registered 505 participants enrollment target is mid-sized for trials with a published cap, above the 140-participant average among 5 other Arthroplasty trials with a reported enrollment target (261% higher).

The record links to 2 conditions, with Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Betadine Lavage is the first listed.

NCT01175044 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01175044 about?

NCT01175044 is a clinical study titled "Dilute Betadine Lavage in the Prevention of Postoperative Infection". The purpose of this study is to examine the efficacy of a dilute betadine solution in reducing infectious complications in revision total knee arthroplasty. The investigators will enroll patients who are scheduled to undergo a revision total knee arthroplasty. Patients will be randomized into two gr...

What is the current status of trial NCT01175044?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 505 participants. The study started on 2010-08. Estimated completion is 2019-07-08.

What conditions does trial NCT01175044 study?

This clinical trial studies the following conditions: Arthroplasty, Prosthesis-related Infections.

What interventions are being tested in trial NCT01175044?

The interventions under investigation include: Betadine Lavage (PROCEDURE), Saline Lavage (PROCEDURE).

Who is sponsoring clinical trial NCT01175044?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01175044 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05069428 · 506 participants · Phase 4

    Delirium Reduction With Ramelteon

  • NCT05797168 · 506 participants · Phase 1

    Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • NCT05846282 · 504 participants · NA

    Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience

  • NCT06072131 · 504 participants · Phase 3

    To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01175044, the US trial registry maintained by the National Library of Medicine. NCT01175044 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.